Monoclonal Antibodies in Multiple Myeloma

Video

Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.

Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.

The two monoclonal antibodies currently approved for treatment in patients with multiple myeloma are elotuzumab and daratumumab. While infusion reactions can occur with these treatments, there are pre-medications recommended. Additionally, most reactions are not usually experienced beyond the first infusion.

To learn more about these treatments, watch Safety of Monoclonal Antibodies in Myeloma.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Image of a woman with gray hair on a light blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a private infusion bay with a large screen for video calls
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a man wearing scrubs in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
Related Content